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Abstract
Early changes in biomarker levels probably occur before bloodstream infection (BSI) is diag-
nosed. However, this issue has not been fully addressed. We aimed at evaluating the kinetics of
C-reactive protein (CRP) and plasma albumin (PA) in the 30 days before community-
acquired (CA) BSI diagnosis. From a population-based BSI database we identified 658 patients
with at least one measurement of CRP or PA from day −30 (D–30) through day −1 (D–1)
before the day of CA-BSI (D0) and a measurement of the same biomarker at D0 or D1.
Amongst these, 502 had both CRP and PA measurements which fitted these criteria. CRP
and PA concentrations began to change inversely some days before CA-BSI diagnosis, CRP
increasing by day −3.1 and PA decreasing by day −1.3. From D–30 to D–4, CRP kinetics
(expressed as slopes – rate of concentration change per day) was −1.5 mg/l/day. From D–3
to D1, the CRP slope increased to 36.3 mg/l/day. For albumin, the slope between D–30 to
D–2 was 0.1 g/l/day and changed to −1.8 g/l/day between D–1 and D1. We showed that bio-
marker levels begin to change some days before the CA-BSI diagnosis, CRP 3.1 days and PA
1.3 days before.
Introduction
Early changes in biomarkers probably occur some days before bloodstream infection (BSI) is
diagnosed. This issue has not been fully addressed in previous clinically based studies, in par-
ticular in community-acquired (CA) infections [1–4]. The assessment of biomarker kinetics
before BSI diagnosis could provide knowledge on the basic understanding of underlying
mechanisms of infection as well as improving the usefulness of biomarker kinetics in the clin-
ical decision-making process.
Hospital-acquired infections frequently occur in patients with other non-infectious con-
ditions that are associated with increased biomarker levels, e.g. previous surgery or IV lines.
As CA infections occur in a previously healthier population, without those major inflamma-
tory stimuli, they make a better model for studying biomarker kinetics before infection
diagnosis.
An additional problem is the definite diagnosis of infection. Frequently, we are unable to
obtain the microbiological documentation of an infection. This is particularly true in CA
infections, e.g. due to previous antibiotics prescriptions and difficulty in obtaining good qual-
ity samples for microbiology, in particular in lower respiratory tract infections in patients with-
out tracheal intubation. However, CA-BSI is a well-defined clinical entity based on clear and
globally accepted clinical and microbiological diagnostic criteria [5].
The Danish Observational Registry of Infectious Syndromes (DORIS) is a population-based
research database comprising CA-BSI patients as well as their data before the reference BSI
episode, namely biochemistry and microbiological data [6].
Consequently, the DORIS database enabled us to overcome the above-mentioned limita-
tions of a CA infection definite diagnosis. In the present study, we aimed at evaluating the
kinetics of C-reactive protein (CRP) and plasma albumin (PA) in the 30 days before the
CA-BSI episode.
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Methods
Setting
The Danish national health system is tax financed, covering both
primary and hospital care. All residents have a unique civil regis-
tration number used for all health contacts and linkages between
health administrative registries [7]. The admission of all residents
with acute illnesses from a well-defined geographical region to a
hospital prompted a population-based study based on data from
registries and the medical records in the DORIS research database
[6]. The study was approved by the Danish Data Protection
Agency (record no. 2013-41-2579). Approval by an ethics com-
mittee or consent from participants is not required for registry-
based research in Denmark.
Initial study cohort
The study cohort has been described in detail elsewhere [6]. In
brief, it comprised all adults (>14 year) residing in the Funen
County with the first episode of CA-BSI, in the period 2000–
2008, a total of N = 2785 patients.
A CA-BSI was defined as BSI occurring <3 days after hospital
admission and without inpatient contact in the preceding seven
days. We had all the CA-BSI patients’ hospital recorded CRP
and PA measurements from 2000 through 2008 [8].
Unrealistically low levels of PA (<11 g/l) were excluded. The
CRP values below the limit of detection (<10 mg/l, N = 452
(14.5%)) were randomly allocated to a value in the range
0–9 mg/l, as described elsewhere [8]. From this cohort we have
derived different sub-cohorts based on the occurrence of CRP
and/or PA within pre-specified time periods around the date of
CA-BSI [8–10].
Final study cohort
We included CA-BSI patients with at least one measurement of
CRP or PA from day −30 (D–30) through day −1 (D–1) before
the day of CA-BSI (D0) and a measurement of the same bio-
marker at D0 or D1. D0 is defined as the day the blood culture
is drawn.
Analyses of CRP and PA levels
All analyses were performed by the Department of Clinical
Biochemistry and Pharmacology, Odense University Hospital,
with the results recorded in Netlab (Medasys S.A., Littau,
Switzerland). CRP was measured by an immunoturbidimetry
method on Modular P® (Roche, Mannheim, Germany). PA was
also measured on Modular P® by the use of a bromocresol
green dye-binding method. All specimen dates refer to the date
of drawing blood specimens.
Statistical analysis
CRP levels were not normally distributed whereas PA levels were.
Because the results for means and medians were materially the
same, we report the mean levels. CRP and PA concentrations
were found to change their course prior to D0. This behaviour
was modelled as a broken stick where two linear functions were
defined on two distinct time-intervals, (D–30,c) and(c, D1)
[11]. The intersection of the functions defined c as the point in
time in which the concentration course changed and the
parameters were determined by a broken stick regression (BSR).
Differences in the dynamics of monomicrobial Gram-positive,
monomicrobial Gram-negative and polymicrobial CA-BSIs were
investigated by estimating distributions of the parameter-
differences by a bootstrap algorithm (1000 replications) [12]. A
distribution with a 95%-confidence interval (CI) in which zero
was not included would imply significance for the parameter-
difference.
We used the program Stata, vs. 14 (StataCorp, College Station,
TX, USA) for all analyses.
Results
Among 658 patients, 576 fulfilled the criteria of CRP on D–30/−1
and D0/D1, 584 fulfilled this for PA, whereas 502 patients fulfilled
this for both CRP and PA. The baseline clinical characteristics at
the day of CA-BSI diagnosis are presented in Table 1. The micro-
biological isolates are shown in Table 2.
CRP kinetics before CA-BSI diagnosis
Among the 576 patients, the daily number of measurements was
fairly constant until D–3 (range 44–87), increasing to 98 on D–2,
189 on D–1, 607 on D0, with a decline to 434 on D1 (Fig. 1). The
CRP values were already elevated (>60 mg/l) in most of the 30
days before CA-BSI (Fig. 2, upper panel).
CRP began to increase some days before D0 (Fig. 2, upper
panel). The BSR analysis showed that CRP began to increase at
day −3.1 (95% CI−3.6 to −2.6) (Fig. 2, upper panel, arrow).
The day of CRP change did not differ significantly between
monomicrobial Gram-positive (day −2.8, 95% CI −3.7 to −1.9),
monomicrobial Gram-negative (day −3.1, 95% CI −3.8 to −2.4)
or polymicrobial CA-BSI (day −3.4, 95% CI −4.6 to −2.2) (data
not shown). From D–30 to D–4, the CRP kinetics, expressed as
a slope (rate of concentration change per day), was −1.5 mg/l/
day (95% CI −2.0 to −0.9), whereas the slope was 36.3 mg/l/day
(95% CI 31.3–41.4) from D–3 to D1 (Fig. 2, upper panel, slope
1 and slope 2, respectively). In the two time periods, the slopes
for monomicrobial Gram-positive, monomicrobial Gram-negative
or polymicrobial CA-BSIs were not significantly different (−1.3
(95% CI −2.3 to −0.2), −1.3 (95% CI −2.0 to −0.5) and −2.7
(95% CI −4.2 to −1.2) mg/l/day; 39.7(95% CI 28.6–50.7), 34.0
(95% CI 27.2–40.9) and 40.5 (95% CI 27.3–53.6) mg/l/day).
Focusing on the 226 patients having ⩾2 CRP specimens in
both periods (data not shown) we assessed their individual CRP
kinetics (slopes), from D–30 to D–4 and from D–3 to D1. Most
of the patients presented almost no variation or a slight negative
slope in the first period followed by a marked increase in the days
just before CA-BSI diagnosis in 84.5% of the patients (Fig. 3,
upper panel).
PA kinetics before CA-BSI diagnosis
Among the 584 patients, the daily number of measurements was
fairly constant until D–3 (range 50–89), increasing to 96 on D–2,
176 on D–1, 542 on D0, with a decline to 390 on D1 (Fig. 1).
The PA values were low (<35 g/l, lower limit of the reference
range) in most of the 30 days before CA-BSI (Fig. 2, lower panel).
PA began to decrease before D0 (Fig. 2, lower part). The BSR
analysis showed that PA began to decrease at day −1.3 (95% CI
−2.4 to −0.8) (Fig. 2, lower panel, arrow). For monomicrobial
Gram-positive CA-BSIs, the day of change was −0.3 (95% CI
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−0.8 to 0.2) which was not significantly different from D0. The
day of change for monomicrobial Gram-negative −1.1 (95% CI
−1.7 to −0.6) and polymicrobial −6.4 (95% CI −11.3 to −1.48)
CA-BSIs differed significantly from D0. The days of change for
monomicrobial Gram-positive and monomicrobial Gram-
negative CA-BSIs were not significantly different, whereas num-
bers for polymicrobial CA-BSIs were too low for robust
computations.
From D–30 to D–2 PA kinetics, expressed as a slope, were 0.1
(95% CI 0.03–0.10) g/l/day whereas from D–1 to D1 the slope
changed to −1.8 (95% CI −2.4 to −1.3) g/l/day (Fig. 2, lower
panel, slope 1 and slope 2, respectively). In the first time period,
the slopes of monomicrobial Gram-positive (−0.003 g/l/day, 95%
CI −0.05 to 0.05) and polymicrobial CA-BSIs (0.11 g/l/day, 95%
CI −0.01 to 0.22) were not significantly different from zero. The
slope of the monomicrobial Gram-negative CA-BSI was 0.09 g/l/
day (95% CI 0.05–0.14). In the second time period, the slopes
of monomicrobial Gram-positive −2.9 g/l/day (95% CI −4.3
to −1.5) and monomicrobial Gram-negative −2.3 g/l/day (95%
CI −3.0 to −1.6) were not significantly different. The slope of
the polymicrobial CA-BSI was −0.6 g/l/day (95% CI −1.1 to −0.1).
Focusing on the 210 patients having ⩾2 PA specimens in both
periods (data not shown) we assessed the individual PA kinetics
(slopes), from D–30 to D–2 and from D–1 to D1. We found
that most of the patients presented almost no variation or a
minor positive slope during the first period followed by a negative
slope in the days before CA-BSI diagnosis in 78.6% of the patients
(Fig. 3, lower panel).
Discussion
We found that CRP and PA concentrations began to change
inversely some days before diagnosing CA-BSI, CRP increasing
by day −3.1 and PA decreasing by day −1.3. The assessment of
CRP kinetics clearly showed that before D–3, CRP presented a
slight negative slope followed by a sharp and marked increase
in the days before CA-BSI diagnosis. PA presented an inverse
course in comparison with CRP with a very slight positive slope
before D–1 followed by a decrease.
As already pointed out by our group [8], CRP and PA levels
were not within the normal range before the CA-BSI. The elevated
CRP concentration, >60 mg/l, is much higher than the <10 mg/l
found in healthy Danes [13, 14]. The same was true for PA, show-
ing a slight hypoalbuminemia during the study period. High CRP
and low PA in patients in whom the physician found an indica-
tion to perform blood tests could be a surrogate marker of an
underlying condition associated with some levels of chronic
inflammation before the development of CA-BSI.
The mechanisms of the host response to infection have been
well studied in animal models but such data are difficult to
extrapolate to clinical reality. In daily life, patients frequently go
to their general practitioner or an emergency department with
unspecific clinical complaints which have often lasted for days.
These unspecific conditions may later develop into a full-blown
clinical picture caused by a well-established infection. As a result,
these patients do not present to the emergency departments
Table 2. Microbiological isolates (n = 658)
Text Number (%)
Monomicrobial Gram-positive 224 (34.0)
Staphylococcus aureus 116 (17.6)
Streptococcus pneumoniae 52 (7.9)
Streptococci, other 28 (4.3)
Enterococcus faecalis 28 (4.3)
Monomicrobial Gram-negative 353 (53.6)
Escherichia coli 202 (30.7)
Klebsiella spp. 48 (7.3)
Pseudomonas aeruginosa 35 (5.3)
Other 68 (10.3)
Polymicrobial 81 (12.3)
Table 1. Baseline patient characteristics (n = 658)
Number (%)a
Measurements of CRP and PA
Only CRP measured 74 (11.3)
Both CRP and PA measured 502 (76.3)
Only PA measured 82 (12.5)
Age, years
Mean, S.D. 66.1, 15.6
Females 279 (42.4)
Charlson comorbidity index
0 points 42 (6.4)
1–2 points 278 (42.3)
>2 points 338 (51.4)
Antibiotics redeemed from pharmacy
No redemption 0–30 D before CA-BSI 534 (81.2)
Redemption 8–30 D before CA-BSI 86 (13.1)
Redemption <8 D before CA-BSI 38 (5.8)
Admitted to
Surgical ward 58 (8.8)
Medicine ward 419 (63.7)
Oncology/haematology ward 149 (22.6)
Intensive care unit 32 (4.9)
Sepsis severity
No sepsis 49 (7.5)
Possibly sepsis 120 (18.2)
Sepsis 156 (23.7)
Severe sepsis or septic shock 293 (44.5)
Organ dysfunction without sepsis 40 (6.1)




30-Day mortality 161 (24.5)
CRP, C-reactive protein; PA, plasma albumin; S.D. standard deviation.
aExcept for ‘Age, years’, cf. text.
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within a couple of hours of disease course, as is the case of e.g.
acute myocardial infarction [15].
It is generally difficult to define the beginning of infectious dis-
eases. The DORIS database enabled us to explore the kinetics of
CRP and PA before the clinical diagnosis of CA-BSI. Our study
clearly showed that in these CA-BSI patients, with blood tests per-
formed in the preceding 30 days, CRP began to increase 3.1 days
before the diagnosis and PA began to decline 1.3 days before the
diagnosis. Before these two time-points, both biomarkers
remained fairly unchanged, which was reflected by the very low
slopes. But afterwards, maybe reflecting the initiation of the infec-
tious process and the associated host response, we noticed marked
changes in kinetics with a sharp increase in the CRP slope and a
decrease in the PA slope. This indicates that the infection is a
Fig. 1. Daily number of specimens of CRP and PA from day −30 through day 1 (in relation to the day of the CA-BSI).
Fig. 2. CRP (upper panel) and PA (lower panel) course from day −30 through the day after CA-BSI. The observed mean values (points) are fitted as two linear
functions (lines) which are connected at the point of course change (indicated by an arrow).
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dynamic process that begins to elicit an inflammatory response
before the clinical diagnosis. One could consider that these unspe-
cific clinical manifestations were not severe enough to make the
patient seek medical consultation, or, if they did, the symptoms
were not severe enough to indicate taking blood cultures or hos-
pital admission. But the initial host response to the infection was
already signalled by inverse changes in the CRP and PA slopes.
We could speculate that in patients having a high risk of infec-
tious complications, CRP and PA kinetics, in addition to symp-
toms/signs (such as fever or tachycardia) suggestive of an
infection, could prompt the physician to order further tests (e.g.
blood cultures) and possibly prescribe pre-emptive antibiotic
therapy [16]. Our results also point to the usefulness of the com-
bined use of CRP and PA.
Our study has several strengths. To our knowledge, apart from
two studies in the same cohort [8, 10], no study has assessed lon-
gitudinal measurements of CRP and PA before a CA infection.
Secondly, it comprises a large cohort of CA-BSI episodes, which
increases the robustness and consistency of our findings.
Thirdly, BSIs are infections defined according to well-defined
and globally accepted criteria [17]. Finally, our cohort derives
from a population-based database.
Our study also has several limitations. Firstly, it is retrospective
although the data per se were prospectively collected from registries
and medical records. Secondly, the number of specimen dates per
patient before D0 varied (from 1 to 26) and the measurement of
CRP/PA depended on the physician’s assessment and the patient’s
clinical complaints. However, our study’s main focus was patterns
related to longitudinal data. A recent study comprising 2418 of the
initial larger cohort of 2785 patients [6] showed that these patterns
were materially the same regardless of the numbers of specimens
[10], which facilitates the extrapolation of results between patient
groups having different numbers of specimens in the different
time periods around CA-BSI. Thirdly, we had not enough clinical
data to interpret whether the abnormal CRP and PA levels before
the day of slope change could reflect an underlying disease causing
some degree of chronic inflammation. We speculate that CA-BSI
patients with no blood tests before D0 would be healthier, and con-
sequently would have lower CRP and higher PA. Our group has
also found that this latter group had 50% lower 30-day mortality
[10]. Fourthly, the D0 was influenced by two variables that cannot
be controlled in studies on CA-BSI, one is the patient’s own deci-
sion to attend an emergency department and the other is the phy-
sician’s own decision to collect blood cultures. Fifthly, we had no
data on nutrition. However, for the larger CA-BSI cohort we
found a high negative correlation (R =−0.47, P < 0.0001) between
61 583 paired CRP and PA specimens, clearly indicating hypoalbu-
minemia as a marker of an underlying chronic inflammation [8].
This is also in accordance with several reviews [18, 19]. Sixthly,
our definition of CA differed from the more generally accepted def-
inition of healthcare-associated infection [20] as many of our
patients had a hospital contact in the 30 days before their
CA-BSI episode [21]. However, this probably has little impact on
biomarker kinetics before CA-BSI [10].
In conclusion, biomarker levels began to change some days
before the CA-BSI diagnosis. For these patients, a sudden increase
in the CRP followed shortly thereafter by a PA decrease could sig-
nal a high risk of CA-BSI.
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Fig. 3. Scatter plots of CRP individual slopes from day −30 (D–30) through day −4 and from day −3 through the day after CA BSI (D1) (226 patients) and PA indi-
vidual slopes from D–30 through day −2 and from day −1 through D1 (210 patients). Patients with monomicrobial Gram-positive CA-BSI are presented as dots, with
monomicrobial Gram-negative CA-BSI as triangles, and with polymicrobial CA-BSI as circles.
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